U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06850948) titled 'Experiences of Healthcare for Autistic TGD Adults' on Feb. 26. Brief Summary: To explore t... Read More
U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852248) titled 'Ureteric Identification Using Indocyanine Green Dye Versus Conventional Ureteric Stenting t... Read More
U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852157) titled 'Evaluation of the Diagnostic and Prognostic Value of Immunohistochemical Markers in Precanc... Read More
U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852430) titled 'Factors Associated With Advanced HIV and Poor Nutrition Among People Living With HIV' on Fe... Read More
U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06851286) titled 'Effects of Laughter Therapy on Postpartum Mothers' Stress, Sleep, and Breastfeeding' on Feb... Read More
U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06851858) titled 'Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obes... Read More
U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06850935) titled 'Evaluation of Effects on Skin Quality of a Centella Asiatica Extracellular Vesicle-based Sk... Read More
U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06850922) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 A... Read More
U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852339) titled 'Evaluating the EAPOC-COPD System' on Feb. 20. Brief Summary: The EAPOC-COPD study is a ste... Read More
U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852222) titled 'A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Acute ... Read More